# A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

> **NCT06617390** · — · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 1041 (actual)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **OTHER:** No drug

## Key facts

- **NCT ID:** NCT06617390
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-15
- **Primary completion:** 2025-01-26
- **Final completion:** 2025-07-30
- **Target enrollment:** 1041 (ACTUAL)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06617390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06617390, "A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06617390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*